Furthermore, while adoptive transfer of RA-associated CD4+ T cells from patients led to RA-like joint pathology and inflammation in humanized chimeric NSG mice, pre-treating these T cells with exogenous healthy mitochondria substantially ameliorated the development of joint disease (Figure 1C). The gene discussed is CD4; the disease is rheumatoid arthritis.